|
|
December 8, 2010 
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Coiuncil
enany@socalbio.org
www.socalbio.org
|
| SoCalBio Mourns the Passing of Noted Southland Economist and Biomed Industry Friend Jack Kyser
| Jack Kyser, for decades the go-to guru on the Southern California economy for government officials and journalists, has died. He was 76. Read more
|
SoCalBio Video Clip
| Watch the Final Cut of the SoCalBio Investor Conference Video Recap
| 
Click on image or HERE to see the video
Mark your Calendar
The 13th Annual SoCalBio Investor Conference will be held on September 22, 2011 (location: TBA)
Sponsorship and Vendor Display Opportunities Available
|
RSVP Now
| SoCalBio Holiday Dinner
December 16, 2010 -- UCLA Faculty Center
RSVP Now
This dinner will feature successful bioscience incubators in Los Angeles and Orange County including: - Momentum Biosciences (Culver City)
- Incuvate (Irvine)
You will have the opportunity to meet the CEOs of device and biotech companies at the above mentioned incubators; and learn about the new technologies and products under development. RSVP now
|
Coming in February 2011
| RSVP to Attend the California Conference on Bioscience Cloud Computing
Feb. 24, 2011 -- Jonathan Club (Los Angeles)
RSVP: https://www.123signup.com/register?id=mbmsg
Sponsorship and Vendor Display Opportunities Available
Cloud computing is a paradigm shift helping research labs and companies leverage internal and external clouds for collaboration, calculations, and data management. This conference will cover real-world use cases across daily business needs, from R&D to marketing. More info: http://www.socalbio.org/calendar/Cloud_Computing/Cloud_Computing_Flyrer.pdf
|
 |
| | Welcome New SoCalBio Members |
 (Pasadena)
Maven is a privately held biotechnology company developing the LFIRE, a flexible, cost effective, label free, high density imaging system for quantitative biomarker analysis that can characterize molecular binding reactions in real-time.... Learn more
(Los Angeles)
JETRO helps U.S. companies set up an office in Japan quickly & cost effectively by providing expertise, resources, and industry connections. Because JETRO is an independent agency of the Japanese government, we are able to provide many of our services for free... More info
CBR Capital Advisors
(Santa Monica)CBR makes healthcare investments and will be represented in SoCalBio By Dr. Jesse kramer jokbiz@pacbell.net |
|  |
Presentations
| | Can Los Angeles be Saved? |  Access a provocative presentation by renowned author and futurist Joel Kotkin about restoring the economic competitiveness of Los Angeles and California. This presentation was made during the 12th Annual SoCalBio Conference held on November 4, 2010 at the J W Marriott of L.A. Live. Click here to access presentation (File is big. It takes time to load up)
|
Market trends
| | Are Hospital Buying Practices Suffocating Medical Device Companies? | Medical-device makers, already battling slumping markets and sliding product prices, are losing their grip on a key tool for driving sales--influence over doctors. This is due to hospitals acquiring doctors' practices, which puts physicians closer to hospital administrators who want to control costs for pricey devices like implantable defibrillators and replacement hips ... Read more
|
Funding
| | SOFIE BIOSCIENCES RAISES $2M TO SUPPORT DEVELOPMENT OF DIAGNOSTIC IMAGING AGENTS AND DEVICES | The Culver City-based Sofie Biosciences, a developer of products for the molecular imaging of disease, announced today the closing of an additional $2 million from new and existing investors. Funds will be used for the development of new PET imaging agents and systems. The round includes the first institutional and corporate financing to the firm including investment by the Cycad Group ... Read more
|
Clinical Studies
| | Xencor and MorphoSys Initiate Phase 1 Study of Anti-CD19 Antibody in Chronic Lymphocytic Leukemia |  "This is the fourth high ADCC antibody based on our XmAb technology that has reached the clinic, demonstrating the tremendous progress our optimization technologies have made in producing next-generation biological drugs," said Bassil Dahiyat, Ph.D., CEO of Xencor (photo right). "We'll be collaborating with our new partner MorphoSys through Phase 1, and are sure that their antibody expertise and product development capabilities will help accelerate the compound's clinical progress" ... Read more
| | MP Biomedicals Receives IND Approval to Commence Clinical Trials for Its HTLV-I/II Screening and Confirmatory Tests | | The Santa Ana-based MP Biomedicals announced that it has received approval of its investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to start pivotal clinical trials in the USA with the MP Diagnostics HTLV-I/II ELISA 4.0 and HTLV Blot.2.4. Studies will be conducted within the American Red Cross, the California Department of Public Health, and LABS, Inc ... Read more |
Partnerships
| | Canoga Park-Based One Lambda and Luminex Renew Long-Term Strategic Partnership |  Companies mark 10-year collaboration anniversary of developing innovative products for organ transplant patients ... Read more
| | Monrovia-Based Prolacta Bioscience Announces Renewed Agreement with International Breast Milk Project |  Under the five-year agreement, which began November 20, 2010, Prolacta will process all donor breast milk collected through IBMP. Processing donor breast milk is a critical step prior to shipment because it ensures the milk's safety. Prolacta's unique milk processing includes donor screening, DNA matching to ensure donor identification, drug testing, pasteurization, final product testing, labeling, and packaging ... Read more |
Product Launch
| | ROX Medical Initiates First Commercial Activities in Germany of Minimally Invasive CO2UPLER Implant in Conjunction with a Phase IV Registry for Patients with Chronic Obstructive Pulmonary Disease (COPD) |  The San Clemente-based Rox Medical's ROX FLO2W Procedure is a percutaneous interventional approach intended for treatment of patients with COPD. The minimally invasive procedure introduces the ROX CO2UPLER device, a small metallic stent-like implant that couples two blood vessels together in the pelvic region. The implant creates a fistula, a calibrated passage, between the artery and vein, which allows a calculated amount of oxygen-rich blood to be rerouted from the artery to the vein, returning back to the heart and lungs for further increased oxygen saturation ... Read more |
Obesity
| | FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND Adjustable Gastric Banding System for Obese Adults |  The Irvine-based Allergan, Inc. announced the FDA Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition .... Read more |
Jobs
|
LA Basin Clinical and Translational Science Institute (Los Angeles)
USC Stevens Institute (Los Angeles)
Allvivo Vascular (Lake Forrest)
Neumedicines (Pasadena)
LA BioMed (Torrance)
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
|
|
